摘要
1 IntroductionOver the last several decades, although there have beenadvances in the treatment of diseases such as children leukemia, Hodgkin's disease, and testicular cancer, however,
1 Introduction
Over the last several decades, although there have been advances in the treatment of diseases such as children leukemia, Hodgkin's disease, and testicular cancer, however, the survival of patients with the most common malignancies such as lung, breast, liver, and colon cancers has not changed significantly. Most of patients will relapse and ultimately died of the disease. The scarce efficacy of current treatments indicates the resistance of cancer cells to cytotoxic agents, radiation, and even immunotherapy and survival from the treatment without major injure.
出处
《中国肺癌杂志》
CAS
2009年第1期3-7,共5页
Chinese Journal of Lung Cancer